Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Metall Zug AG ( (CH:METN) ) has issued an announcement.
Shareholders of Metall Zug AG approved all motions put forward by the Board of Directors at the company’s 139th ordinary general meeting in Zug, including the management and financial reports as well as the 2025 sustainability report. The meeting confirmed all existing board members, re-elected Chairman Martin Wipfli, endorsed board and management compensation, and backed the decision to waive a dividend for 2025 and carry forward retained earnings, signaling a focus on reinvestment and continuity.
In addition, shareholders approved both prospective fixed remuneration for Group Management for 2027 and retrospective variable compensation for 2025, underscoring support for the current governance and incentive structure. A guest presentation by Haag-Streit’s CEO highlighted innovation in the ophthalmology market, aligning with Metall Zug’s strategic emphasis on its medical devices activities ahead of the next annual meeting scheduled for April 2027.
More about Metall Zug AG
Metall Zug AG is an industrial holding group headquartered in Zug, Switzerland, employing around 900 people across three business units: Medical Devices, Technologiecluster & Infra, and Investments & Corporate. The group also holds significant stakes in listed companies V-ZUG Holding, Komax Holding and the joint venture SteelcoBelimed, and its own shares trade on the Swiss Reporting Standard of SIX Swiss Exchange.
Average Trading Volume: 152
Technical Sentiment Signal: Sell
Current Market Cap: CHF326.3M
For an in-depth examination of METN stock, go to TipRanks’ Overview page.